Concept information
Terme préférentiel
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Type
-
mesh:Descriptor
Définition
- A vaccine containing L1 capsid proteins from four types of HPV (ALPHAPAPILLOMAVIRUS), types 6, 11, 16 and 18 that is used to prevent infections from human papillomaviruses of these subtypes.
Concept générique
Qualificatif(s) autorisé(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- antagonists & inhibitors (Qualifier)
- biosynthesis (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- genetics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Traductions
-
français
-
Vaccin recombinant quadrivalent contre les papillomavirus humains (types 6, 11, 16, 18)
-
Vaccin recombinant quadrivalent contre les papillomavirus humains (types 6, 11, 16, et 18)
-
Vaccin recombinant quadrivalent contre les virus du papillome humain (types 6, 11, 16 et 18)
-
Vaccin recombinant quadrivalent contre les virus du papillome humain (types 6, 11, 16, 18)
-
Vaccin recombinant quadrivalent contre les virus du papillome humain de type 6, 11, 16 et 18
URI
http://data.loterre.fr/ark:/67375/JVR-R8N3LL7Q-S
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}